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Abstract
Hair follicle stem cells (HFSCs) normally give rise to 
keratinocytes, sebocytes, and transient amplifying 
progenitor cells. Along with the capacity to proliferate 
rapidly, HFSCs provide the basis for establishing a 
putative source of stem cells for cell therapy. HFSCs are 
multipotent stem cells originating from the bulge area. 
The importance of these cells arises from two important 
characteristics, distinguishing them from all other adult 
stem cells. First, they are accessible and proliferate for 
long periods. Second, they are multipotent, possessing 
the ability to differentiate into mesodermal and 
ectodermal cell types. In addition to a developmental 
capacity in vitro , HFSCs display an ability to form 
differentiated cells in vivo . During the last two decades, 
numerous studies have led to the development of an 
appropriate culture condition for producing various cell 
lineages from HFSCs. Therefore, these stem cells are 
considered as a novel source for cell therapy of a broad 
spectrum of neurodegenerative disorders. This review 
presents the current status of human, rat, and mouse 
HFSCs from both the cellular and molecular biology 
and cell therapy perspectives. The first section of this 
review highlights the importance of HFSCs and in vitro  
differentiation, while the final section emphasizes the 
significance of cell differentiation in vivo .
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Core tip: Hair follicle stem cells (HFSCs) can proliferate 
in vitro  and retain the label for a long time. Various 
types of stem cells, including epidermal-neural crest 
stem cells, nestin-positive, keratin 15-negative cells, 
and CD34-positive cells have been demonstrated in 
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hair follicles. HFSCs normally give rise to keratinocytes, 
sebocytes, and transient amplifying cells in vivo . In 
addition, these cells differentiate into ectodermal 
lineages including oligodendrocytes, astrocytes, and 
neurons. Neural cells derived from HFSCs can replace 
lost cells in neurodegenerative diseases. Their easy 
accessibility along with their potential for neural 
differentiation makes HFSCs an ideal stem cell source 
for treatment of neurodegenerative disorders.
Najafzadeh N, Esmaeilzade B, Dastan Imcheh M. Hair follicle 
stem cells: In vitro and in vivo neural differentiation. World J 
Stem Cells 2015; 7(5): 866-872  Available from: URL: http://
www.wjgnet.com/1948-0210/full/v7/i5/866.htm  DOI: http://
dx.doi.org/10.4252/wjsc.v7.i5.866
INTRODUCTION
Skin stem cells reside in the stratum basale of the 
epidermis, sebaceous glands, and bulge area of the 
hair follicles. A promising start to derive hair follicle 
stem cells (HFSCs) was made in the early 1990s, 
when it was found that label-retaining cells were 
located in the upper portion of the hair follicle (bulge 
area). Subsequently, it was clarified that during the 
early anagen phase, the bulge cells grew downward 
in response to the stimulating factors of the dermal 
papilla cells and formed half of a hair follicle, which 
was degenerated during the catagen phase. Studies 
on hair follicles suggest that mouse HFSCs occupy a 
relatively fixed location in the hair follicle called the 
bulge area, which is important for hair follicle cycling[1]. 
HFSCs continuously supply new cells to the bulb 
during the anagen phase[2], and have the ability to 
differentiate into most of the ectodermal lineages[3]. 
These characteristics make them a promising cell 
source for grafting in various skin and nervous system 
diseases[4].
Kobayashi et al[5] has shown that the bulge area of 
rat whisker follicles contains colony-forming stem cells 
that can be expanded continuously on the feeder cell 
layer and form 95% of the total colonies. Moreover, 
the bulge cells form larger colonies than the non-bulge 
keratinocytes[6]. HFSCs have been seen to be able to 
differentiate either in vitro or in vivo upon grafting into 
a spinal cord injury (SCI)[7,8] and Alzheimer disease 
(AD)[9] animal models. The isolation of human HFSCs 
has generated tremendous interest, because the 
information gained from the study of human HFSCs, 
particularly those regarding cell differentiation, is of 
particular importance[10].
The neural potential of HFSCs was first reported 
by Sieber-Blum et al[11] and Amoh et al[12] who 
demonstrated that the population of HFSCs could be 
converted into Schwann cells after pretreatment with 
neuregulin-1 or upon transplantation into a severed 
sciatic nerve and SCI. Since then, many studies 
used inducers for neural differentiation of HFSCs, 
including neurotrophin-3 (NT-3)[13], a glial cell line-
derived neurotrophic factor (GDNF), a brain-derived 
neurotrophic factor (BDNF)[14], a serum-free medium, 
all trans retinoic acid (RA), and other chemical neural 
inducers[15]. 
In this review, we have summarized the progress 
achieved in both the proliferation and neural lineage 
differentiation of HFSCs. Research on the application 
of stem cells for the treatment of neurodegenerative 
diseases such as peripheral nerve lesions, SCI, and AD 
has created a growing interest in the field of biology. 
Ultimately, a good knowledge of the wide variety of cell 
differentiation will provide the therapeutic application 
of HFSCs in degenerative nervous system diseases and 
skin pathologies. 
MAINTAINING HFSCS 
HFSCs were initially identified in the bulge area of rat 
hair follicles[5]. In 1990, Cotsarelis et al[1] suggested 
that follicular stem cells retain the label and are slow 
cycling. Similarly, Morris et al[16] demonstrated that 
bulge cells are quiescent and maintain a label for a long 
time following induction of anagen. The label-retaining 
cells divide asymmetrically into both identical copies 
of themselves and transient amplifying cells[1,17]. The 
initial HFSCs culture is established and maintained by a 
co-culture, with a feeder layer of 3T3-J2 fibroblasts[5]. 
Subsequent studies have revealed that the epidermal 
growth factor (EGF) and a basic fibroblast growth 
factor (b-FGF) are the feeder molecules that play a 
significant role in the maintenance and proliferation of 
these cells[18,19]. HFSCs can also be grown in a medium 
supplemented with EGF, cholera toxin, insulin, and 
hydrocortisone[13]. Sieber-Blum et al[11] suggests that 
epidermal neural crest stem cells (Epi-NCSCs) are 
pluripotent stem cells residing in the bulge area and 
can also be expanded continuously in the presence of 
an alpha-modified MEM medium, 5% chick embryo 
extract, and 10% of fetal calf serum. With these new 
culture conditions, it is now possible to grow HFSCs 
with defined factors in the absence of a feeder cell 
layer. 
CELL SURFACE MARKERS
HFSCs can be routinely isolated from hair follicles and 
expanded in vitro to cell populations that are similar to 
the adult stem cells in respect to morphology and cell 
surface markers. In fact, numerous subsets of stem 
cells with varying differentiation potentials have been 
demonstrated in hair follicles, such as, Epi-NCSCs[9,11], 
nestin-positive, and keratin 15-negative cells[20], CD34-
positive cells[15,21], and CD200 -positive cells[22].
Mouse bulges cells express specific markers 
including CD34 and K19, as well as CD200 and 
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K15[23]. Expression of CD200 protects the bulge area 
from inflammation and hair loss in alopecia areata[24] 
and these cell surface protein is the best positive 
marker for the human bulge stem cells[22]. A central 
problem is the lack of a specific and reliable marker 
for the identification of HFSCs. Among the different 
markers, CD34 is possibly the most promising 
marker for HFSCs[25]. Previously, bulge cells were 
isolated from mouse, rat, and human cells by manual 
dissection, but the purity of the isolated cells was 
unclear. Several years ago, Ohyama et al[22] used 
laser capture microdissection for precise bulge cell 
isolation. Now different isolation methods for bulge 
stem cells are accessible using CD34 as a hair follicle 
stem cell surface marker, by fluorescence-activated 
cell sorting (FACS)[26] and magnetic activated cell 
sorting (MACS)[8,27]. Therefore, the precise isolation 
of HFSCs having the ability to differentiate into many 
different cell types has generated a promising field for 
therapeutic application.
Some bulge stem cells are K15-positive and nestin-
negative and differentiate into keratinocytes[28]. More 
recently, Snippert et al[29], reported Lgr6 expression in 
HFSCs, which differs from Lgr5/CD34+ HFSCs. Lgr6+ 
HFSCs particularly express Sca-1, α6-integrin, β1-
integrin, sox9, and Lhx2, and contribute to wound 
repair. Sieber-Blum et al[7], showed that the other 
type of HFSCs express neural crest genes as well as 
neural stem cell markers, indicating a neural crest 
origin and neural differentiation potential. The other 
types of HFSCs in mouse hair follicles are called nestin-
positive stem cells. These cells express some stem 
cell markers such as CD34, and can differentiate into 
non-follicular cell types, such as, neural cells[30], which 
are maintained in the presence of FGF2 and a low 
concentration of B27[20]. Nestin-positive cells exhibit a 
colony forming potential in vitro and are small oval or 
round shaped, with a dendrite-like structure. At the 
anagen stage, nestin-expressing cells form the lower 
part of the hair follicle[30]. 
MULTIPOTENCY OR PLURIPOTENCY
This is an open question of whether bulge stem 
cells isolated from the hair follicle are pluripotent or 
multipotent cells and whether truly pluripotent cells 
can be isolated from the hair follicle by expansion, in 
vitro. HFSCs are considered to be multipotent cells 
because they differentiate into ectodermal derivatives 
such as neural cells, astrocytes, oligodendrocytes, 
and Schwann cells[14], as well as mesodermal line-
ages, including chondrocytes[11], myocytes[31], adi-
pocytes, and osteocytes[17]. However, the expression 
of differentiation markers is often insufficient to 
conclude whether a cell has converted to a new state 
of differentiation[32]. Bulge cells can proliferate and 
differentiate into the bulb keratinocytes at the onset of 
the anagen phase[2,33]. In addition it is shown that these 
stem cells can also emigrate and continuously provide 
progenitors, regenerating the epidermis and sebaceous 
gland[34-36]. 
 EP-NCSCs derived from the mouse vibrissae hair 
follicle express neural stem cell markers, such as 
Nanog and Oct4[37]. The neural crest transcription 
factors such as nestin, Slug, Snail, Twist, Sox9, Sox10, 
Wnt-1 and BMP4 play essential roles in maintaining 
the undifferentiated state of bulge cells[11,31]. The role 
of these transcription factors in neural crest stem 
cell renewal has been recently reviewed[38,39] and we 
are not going to discuss further. Together, HFSCs has 
an extensive developmental potential, however, it 
is necessary to evaluate the multipotency of HFSCs 
by differencing, in vivo, after cell grafting. For this 
purpose, HFSCs are transplanted into the skin[40], 
SCI[8], peripheral nerve injury and AD[9] models. 
The results suggest that HFSCs have extensive 
developmental potential. Further studies are required 
to determine whether the population of HFSCs can 
give rise to endodermal derivatives. Finally, the 
pluripotency of all subpopulations of HFSCs remains an 
unproven concept, but it seems that only Epi-NCSCs 
express two pluripotency factors, such as, Oct-4 and 
nanog[11].
IN VITRO NEURAL DIFFERENTIATION OF 
HFSCS 
HFSCs attract attention not only in dermatology, but 
also in the treatment of nervous system diseases. It has 
been shown that HFSCs retain the ability to generate 
differentiated progeny in vitro. Many differentiation 
approaches have been optimized using growth factors 
and other inducing factors. These protocols can also 
successfully generate certain lineages. HFSCs can be 
induced to produce an enriched population of glial and 
neuronal lineages following incubation in exogenous 
growth factors[14]. On account of the diversity of 
HFSCs, differentiation and the proliferative potential of 
HFSCs is strongly dependent on the exogenous growth 
factors. Neuroregulin-1 has been found to be required 
for differentiation of HFSCs to Schwann cell and β-Ⅲ 
tubulin positive neural cells. The Epi-NCSCs can also 
differentiate into smooth muscle cells in response to 
bone morphogenetic protein-2 (BMP-2)[11].
Of late, Ghoroghi et al[13], isolated rat HFSCs and 
cultured them on a poly-l-lactic acid (PLLA) scaffold 
to provide a suitable microenvironment for neural 
differentiation, and then used NT-3 to induce neural 
differentiation in the HFSCs.
New protocols have been developed to generate 
neural cells from HFSCs. Of late, we have isolated 
CD34+ cells from the mouse hair follicle, using MACS, 
and then we applied RA, serum-free medium, and 
chemical treatments such as β-mercaptoethanol (BME), 
butylated hydroxyanisole (BHA), and dimethyl sulfoxide 
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about 2.5 million people, affecting the patients and 
society. Unfortunately, no effective treatment has been 
discovered for SCI to date[44]. However, some studies 
are under way to promote regeneration and neural 
repair in patients with SCI[45]. Cell therapy plays a major 
role in axonal regeneration and neuronal replacement 
in AD[9], SCI, and other nervous system diseases. 
Potential strategies to repair neurodegenerative 
diseases include neuronal and glial replacement, 
axonal regeneration and remyelination, and increased 
production of neurotrophins by grafted cells[46,47]. 
Various cell types have been assessed to repair central 
and peripheral nervous system disorders, such as, 
fetal tissue, olfactory ensheathing glia, Schwann cells, 
skin derived precursors, mesenchymal stem cells, and 
HFSCs[48]. To this end, in this part of the review, we 
have focused on the transplantation of HFSCs in SCI.
Preclinical studies have shown a novel type of 
HFSCs known as Epi-NCSCs, which survive and differ-
entiate into βⅢ-tubulin, glutamic acid decarboxylase 
(GAD67), RIP positive, and myelin basic protein-
positive neural cells, but not Schwann cells, when 
transplanted into the contusion model of the SCI; the 
cells can be even integrated with host neurites in the 
contused spinal cord. However, the transplanted cells 
do not form tumors[7]. In another study, extensive 
Schwann cell differentiation of nestin-positive HFSCs 
has been reported after transplantation into a severed 
spinal cord. They have found that the differentiated 
cells facilitated the repair of SCI and promoted hind 
limb function recovery[49]. Likewise, when rat HFSCs 
are transplanted into a compression model of SCI, 
they generate oligodendrocytes and neuron-like 
cells expressing RIP and β-Ⅲ tubulin, respectively. 
Walking scale, limb coordination, and plantar stepping 
improved following HFSC transplantation[8]. Consistent 
with this study, Hu et al[50], also demonstrated that 
unilateral bulge-derived Epi-NCSC transplantation into 
a contused spinal cord promoted a 24% recovery in 
sensory connectivity and touch perception. Moreover, 
some grafted Epi-NCSCs differentiated into functional 
motor neurons. In vivo studies using Epi-NCSCs 
isolated from the mouse hair follicle showed similar 
results[7]. Briefly, these studies showed the safety of 
HFSC transplantation and enhanced recovery in animal 
models of SCI.
Damage to the peripheral nerve interrupts the 
axonal pathways and causes partial or total loss of 
motor, sensory, and autonomic functions. An important 
aim for the ongoing research is the development 
of therapeutic strategies that enhance axonal rege-
neration and replace lost neural cells, to bridge the gap 
of the lesion[51].
HFSCs possess a self-renewal ability and neural 
differentiation potential. Amoh et al[12,52] transplanted 
HFSCs in the severed sciatic nerves of mice. Eight 
weeks after grafting, many spindle cells grew in the 
severed sciatic nerve rather than in the control, differ-
(DMSO), for the neural differentiation in these cells. We 
have found that the serum-free condition and 1 µmol/L 
RA appropriately triggered neurogenesis in HFSCs[15]. 
In addition, it seems that prolonged serum deprivation 
induces formation of the ectodermal derivatives[41]. 
However, chemical treatments with DMSO, BME, BHA, 
and potassium chloride (KCL) induced rapid changes 
in cell morphology, which led to the CD34+ cells dying 
within seven days of treatment[15]. It will be important 
to determine whether the neural cells derived from 
HFSCs possess the functional characteristics of neurons. 
Therapeutic application of HFSCs
HFSCs have advantages and disadvantages regarding 
the potential use of cell-based regenerative therapies. 
The main potential advantage of the HFSCs is that 
they are easily accessible adult stem cells, which have 
ectodermal differentiation potential[15]. Moreover, 
HFSCs are attractive tools for future burn and 
neurodegenerative disease treatments. 
HFSCs are similar to embryonic stem cells and have 
a high proliferative potential in vitro. Similar to other 
types of adult stem cells, they do not form tumors. 
Without a doubt, autologous transplantation and 
avoiding immune rejection has been demonstrated in 
HFSC-treated animal studies[7,12,42].
HFSCs have the properties to differentiate into 
various neural cell types including neurons, astrocytes, 
oligodendrocytes, and Schwann cells. Among them 
some specific cell types can be produced in high 
purity, such as, Schwann cells, motor neurons, and 
oligodendrocytes, which are the main cells that 
degenerate in SCI, peripheral nerve lesions, and AD. 
One of the goals of the researchers in this field is to 
generate neural cells from stem cells, with the aim 
of replacing lost tissue in degenerative disorders. 
Therefore, we have used HFSCs as an alternative cell 
source for cell therapy in nervous system diseases. AD 
is one of the most common neurodegenerative disor-
ders affecting about four million people throughout the 
world each year. AD brains have been characterized 
by amyloid β peptide plaque and neurofibrillary tangle 
formation, which leads to axonal transport defects 
and synaptic loss responsible for cholinergic neuron 
degeneration[43]. 
HFSCs have the potential to constitute an ana-
tomical nervous system structure. Thus, in the case of 
an AD model, these cells are capable of replacing the 
degenerated neurons. In a recent study, researchers 
transplanted a subtype of HFSCs (Epi-NCSCs) to 
differentiate into cholinergic neurons in the AD rat 
model. These stem cell-derived cholinergic neurons 
improved learning and memory deficits in the AD 
model. In spite of rare studies on the therapeutic 
effects of Epi-NCSCs in an AD model[9], it will be 
possible to modify HFSCs to deliver neurotropic factors 
that modify the course of the disease, in the future. 
It is well known that SCI induces paralysis in 
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entiated extensively into Schwann cells, and promoted 
motor function.
In another study, extensive neuronal differentiation 
of the nestin-expressing cells was reported after 
transplantation of RA-pretreated cells into the tran-
sected distal sciatic nerve. In this study, the nestin-
positive bulge cells grew in the distal sciatic nerve 
stump and caused locomotor recovery owing to the 
presence of many Tuj1, Is11/2, and EN1-positive cells 
and nerve fibers. Muscle atrophy was also reduced 
after grafting, and re-innervation was promoted[53]. 
HFSCs transplanted to the subcutis and severed sciatic 
nerve also differentiated into blood vessels[40] and 
Schwann cells[12], respectively. It seemed that the 
differentiation of HFSCs supported neural regeneration 
and motor function of the lower extremity muscles, 
such as, the gastrocnemius[12].
There are still many problems that need to be 
resolved before HFSCs can be widely used clinically. 
The main problem is that approximately only a few 
neural cells derive from these stem cells in vivo and 
further studies are required to determine whether 
the differentiated neurons are functionally integrated 
into the AD brain, SCI, and peripheral nerve lesion 
tissues. Some other forms of cell differentiation, such 
as keratinocytes, myocytes, and melanocytes are 
the other disadvantages of HFSC transplantation in 
neurodegenerative disorders. The successful directed 
differentiation of HFSCs into specific neurons with 
the help of different neural induction methods may 
make neural transplantation widely available for 
neurodegenerative disorders at some point in the 
future.
Collectively, these results indicate that HFSCs can 
promote the recovery of peripheral nerve injury, SCI, 
and AD. Thus, these cells have the desirable properties 
of neural replacement and remyelination.
CONCLUSION
In summary, we have explained that the hair follicle 
contains various multipotent stem cells. The ability 
of HFSCs to proliferate in vitro and the directed 
differentiation toward ectodermal and mesodermal 
lineage cell types render them potential for clinical 
application. These include the modeling of SCI, 
sciatic nerve injury, and AD, studies of cell therapy on 
progression, and amelioration of symptoms. 
At present, HFSC transplantation provides the best 
chance of cure for many diseases. Future studies seek 
to characterize the signaling genes that regulate stem 
cell behavior.
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